Surgery for asymptomatic primary hyperparathyroidism: proceedings of the third international workshop

R Udelsman, JL Pasieka, C Sturgeon… - The Journal of …, 2009 - academic.oup.com
Context: An international workshop on primary hyperparathyroidism (PHPT) was convened
on May 13, 2008, to review and update the previous summary statement on the management …

Primary thyroid lymphomas

S Widder, JL Pasieka - Current treatment options in oncology, 2004 - Springer
Opinion statement Primary thyroid lymphoma is a rare disease that continues to produce
diagnostic and therapeutic dilemmas. There was great difficulty in distinguishing thyroid …

Anaplastic thyroid cancer

JL Pasieka - Current opinion in oncology, 2003 - journals.lww.com
Anaplastic thyroid carcinoma is one of the most aggressive malignancies, with a poor prognosis.
Although rare, representing only 2% of clinically recognized thyroid cancers, the overall …

The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism

…, QY Duh, GM Doherty, MF Herrera, JL Pasieka… - JAMA …, 2016 - jamanetwork.com
Importance Primary hyperparathyroidism (pHPT) is a common clinical problem for which the
only definitive management is surgery. Surgical management has evolved considerably …

Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes

…, V Murday, P Niccoli-Sire, JL Pasieka… - The Journal of …, 2006 - academic.oup.com
Context: The identification of mutations in genes encoding peptides of succinate dehydrogenase
(SDH) in pheochromocytoma/paraganglioma syndromes has necessitated clear …

NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas

…, SJ Goldsmith, DS Klimstra, SJ Marx, JL Pasieka… - Pancreas, 2010 - journals.lww.com
Well-differentiated neuroendocrine tumors (NETs) of the stomach and pancreas represent 2
major subtypes of gastrointestinal NETs. Historically, there has been little consensus on the …

The incidence of bilateral well‐differentiated thyroid cancer found at completion thyroidectomy

JL Pasieka, NW Thompson, MK McLeod… - World journal of …, 1992 - Wiley Online Library
… The report by Pasieka and colleagues shows that significant residual cancer is present in …
of being in both, particularly if as Pasieka and coworkers have shown, the disease is multifocal …

Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin …

…, D Poon, B Gadbaw, J Li, JL Pasieka… - Drug design …, 2015 - Taylor & Francis
In a randomized, double-blind, Phase III study, we compared pasireotide long-acting release
(pasireotide LAR) with octreotide long-acting repeatable (octreotide LAR) in managing …

Patient‐based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism

JL Pasieka, LL Parsons, MJ Demeure… - World journal of …, 2002 - Wiley Online Library
This study assessed the impact of parathyroidectomy on the preoperative symptoms of
patients with primary hyperparathyroidism (1 HPT) using a surgical outcome tool designed …

Prospective surgical outcome study of relief of symptoms following surgery in patients with primary hyperparathyroidism

JL Pasieka, LL Parsons - World journal of surgery, 1998 - Springer
… The study by Pasieka and Parsons consequently adds little in this respect. In the apparently
asymptomatic individuals without apparent complications to HPT, however, the frequently …